The University of Southampton
University of Southampton Institutional Repository

Pharmacist supplementary prescribing: a step towards more independence?

Dawoud, Dalia, Griffiths, Peter, Maben, Jill, Goodyer, Larry and Greene, Russell (2011) Pharmacist supplementary prescribing: a step towards more independence? Research in Social and Administrative Pharmacy, 7, (3), pp. 246-256. (doi:10.1016/j.sapharm.2010.05.002). (PMID:21272547).

Record type: Article


Background: supplementary prescribing (SP) is a drug therapy management model implemented in the United Kingdom since 2003. It is a voluntary partnership between an independent prescriber; a supplementary prescriber, for example, nurse or pharmacist; and the patient, to implement an agreed patient-specific clinical management plan (CMP).

Objective: to investigate pharmacist prescribers' views and experiences of the early stages of SP implementation.

Methods: a qualitative, longitudinal study design was used. A purposive, maximum variability sample of 16 pharmacist supplementary prescribers, trained in Southern England, participated. Eleven were hospital pharmacists, owing to the overrepresentation of hospital pharmacists in the first cohort. Two semistructured interviews were conducted with each participant, at 3 and 6 months after their registration as prescribers. The Framework approach was used for data collection, management, and analysis.

Results: three typologies of pharmacists' experiences were identified: “a blind alley”, “a stepping stone” and “a good fit”. Despite some delays in its implementation, SP was seen as a step forward. Some participants also believed that it improved patient care and pharmacists' integration in the health care team and increased their job satisfaction. However, there was a concern that SP, as first implemented, was bureaucratic and limited pharmacists' freedom in their decision making. Hence, pharmacists were more supportive of the then imminent introduction of a pharmacist independent prescribing (IP) role.

Conclusions: despite challenges, the SP role represented a step forward for pharmacists in the United Kingdom. It is possible that pharmacist SP can coexist with IP in the areas suitable for CMP use. Elsewhere, SP is likely to become more of a “stepping stone” to an IP role than the preferred model for pharmacist prescribing. Future research needs to objectively assess the outcomes of pharmacist SP, preferably in comparison with IP, to inform decision making among pharmacists regarding the adoption of such an innovative role

Full text not available from this repository.

More information

e-pub ahead of print date: 23 July 2010
Published date: September 2011
Keywords: united kingdom, pharmacist, supplementary prescribing, drug therapy management, qualitative, framework analysis


Local EPrints ID: 167313
ISSN: 1551-7411
PURE UUID: 910fd310-2df8-4766-af6f-f137f4e7d776
ORCID for Peter Griffiths: ORCID iD

Catalogue record

Date deposited: 11 Nov 2010 11:23
Last modified: 18 Jul 2017 12:24

Export record



Author: Dalia Dawoud
Author: Peter Griffiths ORCID iD
Author: Jill Maben
Author: Larry Goodyer
Author: Russell Greene

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.